News Search Results
Sep 16, 2025, 09:07 ET NUTRAFOL LAUNCHES 'THE MENOPAUSE EDIT' TO RECLAIM THE NARRATIVE AROUND MENOPAUSE AND HAIR HEALTH
formulations. To remain on the cutting edge of innovation, Nutrafol's team of doctors and researchers continues to explore breakthroughs in genetics, biotechnology, and anti-aging. Today, Nutrafol has been adopted by over 7,500 hair care and healthcare providers5 nationwide for its trusted,
More news about: Nutrafol
Sep 16, 2025, 09:00 ET ExSight Ventures Invests in RevOpsis Therapeutics to Advance Innovative Treatments for Blinding Eye Diseases
capital firm dedicated to investing in transformative ophthalmology innovations, today announced its investment in RevOpsis Therapeutics, a biotechnology company pioneering next-generation therapies for retinal diseases.
More news about: RevOpsis
Sep 16, 2025, 09:00 ET EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic
and transformative solution for women living with endometriosis". About EndoCyclic Therapeutics EndoCyclic Therapeutics is a biotechnology company focused on advancing groundbreaking solutions in women's health. Its lead program, ENDO-205, is the first non-hormonal, disease-modifying
More news about: EndoCyclic Therapeutics
Sep 16, 2025, 08:01 ET Precision Medicine Group Announces Appointment of Tracey Leahy as Chief People Officer
prioritize our team's experience and growth, ensuring we remain the employer of choice for top life science professionals and the partner of choice to biotechnology and pharmaceutical companies worldwide." About Tracey Leahy, Chief People Officer of Precision Medicine
More news about: Precision Medicine Group
Sep 16, 2025, 08:00 ET Coya Therapeutics' COYA 303 Shows Promising Central Nervous System (CNS) Anti-inflammatory Effects and Systemic Regulatory T Cell (Treg) Enhancing Effects in a Preclinical Animal Inflammation Model
Sept. 16, 2025 /PRNewswire/ -- Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, today announced results of a study designed to evaluate the
More news about: Coya Therapeutics, Inc.
Sep 16, 2025, 07:51 ET GCS LAUNCHES ADVANCED AUTOMATED CLEANROOM PANEL MANUFACTURING LINE IN THE U.S.
million sq. ft. of cleanroom paneling annually, supporting accelerated project timelines and precision manufacturing across the pharmaceutical, biotechnology, semiconductor, and advanced manufacturing industries. "It is incredibly rewarding to see our investment and hard work come to life through
More news about: G-CON Manufacturing
Sep 16, 2025, 07:30 ET Yasir Al-Wakeel Appointed CEO of Vesalius Therapeutics and CEO-Partner of Flagship Pioneering
Dr. Al-Wakeel joins Vesalius from multiple prior executive leadership roles guiding the growth of early- and growth-stage biotechnology companies. Previously, he served in senior roles as a biotech equity analyst and in corporate finance, where he was involved in more than
More news about: Flagship Pioneering
Sep 16, 2025, 07:00 ET AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension
Mass., Sept. 16, 2025 /PRNewswire/ -- AllRock Bio Inc., a clinical-stage biotechnology company focused on advancing therapies for cardiopulmonary and fibrotic diseases, today announced a $50 million Series
More news about: AllRock Bio
Sep 16, 2025, 07:00 ET K36 Therapeutics Provides Clinical Update on KTX-1001 in Multiple Myeloma
K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel, targeted therapies for cancers with unmet medical need, today provided a clinical update on its lead asset, KTX-1001 for
More news about: K36 Therapeutics
Sep 16, 2025, 07:00 ET Dualitas Launches With $65 Million Series A to Advance Novel Bispecific Antibody Pipeline in Immune and Inflammatory Disease
compelling activity that monospecific agents cannot achieve. About Dualitas Therapeutics Dualitas Therapeutics, Inc. is a biotechnology company pioneering next-generation bispecific antibody (BsAb) therapies for immunology and inflammation (I&I). Dualitas' portfolio, built from
More news about: Dualitas Therapeutics
Sep 16, 2025, 07:00 ET Oncolytics Biotech® Provides Update on GOBLET Study Progress and U.S. Site Expansion
gastrointestinal tumors where patients desperately need treatment options." About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered double-stranded RNA immunotherapeutic agent. Pelareorep has demonstrated promising results
More news about: Oncolytics Biotech® Inc.
Sep 16, 2025, 07:00 ET Novella Launches Potent Whole-Cell Strawberry Ingredient at SSW
About NovellaNovella Innovative Technology, Ltd. is a biotechnology company pioneering fruit- and vegetable-derived cell complexes for clean, intelligent, and sustainable wellness solutions. Leveraging its proprietary
More news about: Novella
Sep 16, 2025, 05:45 ET BIOVAXYS ANNOUNCES CLOSING OF UNSECURED CONVERTIBLE DEBENTURE OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Sep 15, 2025, 16:30 ET WesternU researchers show Osteopathic Manipulative Treatment improves efficacy of COVID-19 vaccine
Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Sep 15, 2025, 16:01 ET Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr.,
More news about: Innocan Pharma Corporation
Sep 15, 2025, 16:01 ET Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr.,
More news about: Innocan Pharma Corporation
Sep 15, 2025, 12:50 ET Tethered Drone Market is projected to reach US$2,378.12 million by 2031 at CAGR of 29.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 15, 2025, 12:48 ET Diphtheria Tetanus Pertussis (DTP) Vaccine Market Driven by Rising Immunization Programs and Advancements in Healthcare Infrastructure - Market Research Intellect
The DTP Vaccine Market is undergoing transformation due to technological advancements in vaccine research, formulation, and production. Modern biotechnology has enabled the development of safer, more effective, and combination vaccines that reduce the number of injections required for children. Advanced
More news about: Market Research Intellect
Sep 15, 2025, 12:19 ET Butadiene Market Size & Share to Surpass USD 70.95 Billion by 2035, Growing at a CAGR 6.55% | Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 15, 2025, 12:12 ET Rubin Rudman Partners Michael Riseberg and Theodore Folkman Named to 2026 Lawdragon 500 Leading Litigators in America
Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Sep 15, 2025, 11:37 ET Racing Gasoline Market is Projected to Reach US$538.85 Million by 2031 at CAGR of 4.4% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials Contact
More news about: The Insight Partners
Sep 15, 2025, 11:13 ET Cancer Gene Therapy Market Size Worth US$ 19.97 Billion by 2033, with a 19.8% CAGR Growth, Report by DataM Intelligence
international partnerships, as seen at the 2023 ESGCT Congress in Brussels. The UK market is propelled by advancements in biotechnology, increased R&D investment, favorable regulations, and rising cancer cases. Collaborations between academic institutions and biotech firms, along
More news about: DataM Intelligence 4 Market Research LLP
Sep 15, 2025, 10:01 ET Made Scientific and Basilard BioTech Announce Technology Partnership to Advance Ex Vivo Gene Delivery for T Cell and iPSC Therapies
South Korea, a global leader in the pharmaceutical and biotechnology sectors. About Basilard BioTechBasilard BioTech is a Southern California-based biotechnology company revolutionizing the engineering of cell-based therapies. The
More news about: Made Scientific, Inc.
Sep 15, 2025, 09:30 ET HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitor
Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH), congratulates its partner BioAge Labs, Inc. ("BioAge", NASDAQ: BIOA), a clinical-stage biotechnology company based in Emeryville, CA, USA, on the initiation of a Phase 1 clinical study of BGE-102, a novel, potent
More news about: HitGen Inc.
Sep 15, 2025, 09:07 ET Curie Co and Microban International Partner to Advance Preservation Solutions for Cleaning, Paints and Coatings
Sept. 15, 2025 /PRNewswire/ -- Curie Co, an ingredient innovator leveraging biotechnology and conscious chemistry, has partnered with Microban International, a global leader in antimicrobial and odor-control technologies, to deliver next-generation
More news about: Microban International